To secure long-term value-creation and competitiveness, sustainability is an integral part of the organization, actively working to minimize the negative environmental footprint. Getinge is committed to achieving the Paris agreement goals of limiting global warming to 1.5 °C above pre-industrial levels, and has now made the decision to become CO₂neutral by 2025.
Servo-air® is a high performing ventilator intended for adult and pediatric patients and includes both Invasive and Non-Invasive (NIV) ventilation modes, including High Flow Therapy and Servo Compass options.
Getinge Online Enables Hospitals to Improve Efficiency by Using Product Data to Gain Insights and Maximize Uptime
Getinge Online, part of the service offering Getinge Care, is a digital platform to which hospitals can connect their Getinge products to transfer equipment data.
Results from SEMPER FI Pilot Study of Intra-Aortic Balloon Pump Showing Numerical Trend Toward Reduced Mortality in Patients with Extensive Myocardial Infarction and Persistent Ischemia
5/28/18: "Determining which STEMI patients will benefit from IABP has been difficult because of varying results from retrospective and prospective studies," said Dr. van Nunen.
Clinical Trials and Studies
Getinge Announces Results of Study of Contemporary Practice Showing Larger Volume Intra-Aortic Balloon Effective as First-Line Therapy in Patients with Cardiogenic Shock
Company notes: Data Shows Counterpulsation Therapy with 50cc Balloon Represents Safe, Clinically Effective, Cost-Conservative Strategy in Managing Critically Ill Cardiac Patients Getinge, today announced results from a study of contemporary practice demonstrating that intra-aortic balloon counterpulsation (IABC) appears effective...